Effect of Hemodialysis on Serum Concentration of Isepamicin in a Patient with Endstage Renal Failure

Katsu M Saito A . Review: New antimicrobial agent series XXXIV; isepamicin. Jpn J Antibiot 1989; 42: 543–66.

Halstenson CE Shepard-Kelloway J Affrime MB Lin CC Teal MA Shapiro BE . Isepamicin disposition in subjects with various degrees of renal function. Antimicrob Agents Chemother 1991; 35: 2382–7.

Uematsu T Mizuno A Suzuki Y Sato R Yamazaki T Nakashima M . Evaluation of a fluorescence polarization immunoassay procedure for quantitation of isepamicin, a new aminoglycoside antibiotic. Ther Drug Monit 1988; 10: 459–62.

Zaske DE . Aminoglycosides. In: Evans WE Schentag JJ Jusko WJ , eds. Applied pharmacokinetics: Principles of therapeutic drug monitoring. 3rd ed. Vancouver: Applied Therapeutics, 1992: 1–47.

Fillastre JP Singlas E . Pharmacokinetics of newer drugs in patients with renal impairment (part I). Clin Pharmacokinet 1991; 20: 293–310.

Lee CC Marbury TC . Drug therapy in patients undergoing haemodialysis: Clinical pharmacokinetic considerations. Clin Pharmacokinet 1984; 9: 42–66.

Rowland M Tozer TN , eds. Clinical pharmacokinetics: concepts and applications. 2nd ed. Philadelphia: Lea & Febiger, 1989: 420–37.